Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 18.83
- Piotroski Score 2.00
- Grade Buy
- Symbol (NUV)
- Company Nuveen Municipal Value Fund, Inc.
- Price $8.79
- Changes Percentage (0.63%)
- Change $0.06
- Day Low $8.75
- Day High $8.80
- Year High $9.15
Nuveen Municipal Value Fund, Inc. is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States. The fund also invests some portion of its portfolio in derivative instruments. It invests in undervalued municipal securities and other related investments the income, exempt from regular federal income taxes that are rated Baa or BBB or better. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's (S&P) National Municipal Bond Index. Nuveen Municipal Value Fund, Inc. was formed on April 8, 1987 and is domiciled in the United States.
- Last Earnings 11/01/2024
- Ex-Dividend for 5/16 Dividend 11/15/2024
- Dividend Payable 12/02/2024
- Today N/A
- Next Earnings (Estimated) 01/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.26
- Trailing P/E Ratio 32.69
- Forward P/E Ratio 32.69
- P/E Growth 32.69
- Net Income $54.94 M
Income Statement
Quarterly
Annual
Latest News of NUV
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Nuveen's Saira Malik and UBS Wealth's Solita Marcelli on best investment ideas for your portfolio
Saira Malik from Nuveen and Solita Marcelli from UBS Global Wealth Management discuss market opportunities, capital allocation, interest rates, geopolitical risks, and sector rotations at CNBC's Deliv...
By CNBC | 1 week ago -
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug
Nuvectis Pharma, Inc. stock declined due to Phase 1b study results on NXP800 for ovarian cancer. Efficacy was observed with some patients showing tumor responses. The company plans to increase dosage ...
By Yahoo! Finance | 1 week ago -
Nuvve Holding Corp (NVVE) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Revenue ...
Nuvve's CFO reported Q3 2024 revenues of $1.9 million, up from $0.8 million in Q2 2024, with improved gross margins and reduced operating costs leading to a decreased net loss....
By Yahoo! Finance | 1 week ago
